Exelixis
EXEL
#1548
Rank
S$18.22 B
Marketcap
S$73.55
Share price
1.46%
Change (1 day)
47.81%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company